Urinary angiostatin - A novel putative marker of renal pathology chronicity in lupus nephritis

Molecular and Cellular Proteomics

Volumn 12, Issue 5, 2013, Pages 1170-1179

  Wu, Tianfu ^a   Du, Yong ^a   Han, Jie ^a   Singh, Sandeep ^a   Xie, Chun ^a   Guo, Yuyuan ^a   Zhou, Xin J ^b   Ahn, Chul ^a   Saxena, Ramesh ^a   Mohan, Chandra ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID; PLASMINOGEN; PREDNISONE; TACROLIMUS;

ADULT; ANGIOGENESIS; ARTICLE; CHRONICITY; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE COURSE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KIDNEY TUBULE CELL; LONGITUDINAL STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANGIOTENSINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; HUMANS; KIDNEY; LUPUS NEPHRITIS; MALE; PROTEIN ARRAY ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 84877628484     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.021667     Document Type: Article

References (41)

1. Cameron, J. S. (1999) Lupus nephritis. J. Am. Soc. Nephrol. 10, 413-424
2. Iwano, M., Dohi, K., Hirata, E., Kurumatani, N., Horii, Y., Shiiki, H., Fukatsu, A., Matsuda, T., Hirano, T., Kishimoto, T., et al. (1993) Urinary levels of IL-6 in patients with active lupus nephritis. Clin. Nephrol. 40, 16-21 (Pubitemid 23221728)
3. Migliorini, P., Anzilotti, C., Pratesi, F., Quattroni, P., Bargagna, M., Dinarello, C. A., and Boraschi, D. (2010) Serum and urinary levels of IL-18 and its inhibitor IL-18BP in systemic lupus erythematosus. Eur. Cytokine Netw. 21, 264-271
4. Marks, S. D., Shah, V., Pilkington, C., and Tullus, K. (2010) Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis. Pediatr. Nephrol. 25, 2283-2288
5. Wu, T., Xie, C., Wang, H. W., Zhou, X. J., Schwartz, N., Calixto, S., Mackay, M., Aranow, C., Putterman, C., and Mohan, C. (2007) Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J. Immunol. 179, 7166-7175
6. Abd-Elkareem, M. I., Al Tamimy, H. M., Khamis, O. A., Abdellatif, S. S., and Hussein, M. R. (2010) Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings. Clin. Exp. Nephrol. 14, 548-557
7. Brunner, H. I., Mueller, M., Rutherford, C., Passo, M. H., Witte, D., Grom, A., Mishra, J., and Devarajan, P. (2006) Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 54, 2577-2584 (Pubitemid 44205019)
8. Rubinstein, T., Pitashny, M., Levine, B., Schwartz, N., Schwartzman, J., Weinstein, E., Pego-Reigosa, J. M., Lu, T. Y., Isenberg, D., Rahman, A., and Putterman, C. (2010) Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology 49, 960-971
9. Schwartz, N., Rubinstein, T., Burkly, L. C., Collins, C. E., Blanco, I., Su, L., Hojaili, B., Mackay, M., Aranow, C., Stohl, W., Rovin, B. H., Michaelson, J. S., and Putterman, C. (2009) Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res. Ther. 11, R143
10. Liu, Z. C., Zhou, Q. L., Li, X. Z., Yang, J. H., Ao, X., Veeraragoo, P., and Zuo, X. X. (2011) Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Cytokine 53, 295-300
11. Mosley, K., Tam, F. W., Edwards, R. J., Crozier, J., Pusey, C. D., and Lightstone, L. (2006) Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology 45, 1497-1504 (Pubitemid 44817055)
12. Zhang, X., Jin, M., Wu, H., Nadasdy, T., Nadasdy, G., Harris, N., Green-Church, K., Nagaraja, H., Birmingham, D. J., Yu, C. Y., Hebert, L. A., and Rovin, B. H. (2008) Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int. 74, 799-807
13. Wu, T., Fu, Y., Brekken, D., Yan, M., Zhou, X. J., Vanarsa, K., Deljavan, N., Ahn, C., Putterman, C., and Mohan, C. (2010) Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis. J. Immunol. 184, 2183-2193
14. Masuda, Y., Shimizu, A., Mori, T., Ishiwata, T., Kitamura, H., Ohashi, R., Ishizaki, M., Asano, G., Sugisaki, Y., and Yamanaka, N. (2001) Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am. J. Pathol. 159, 599-608 (Pubitemid 32751090)
15. Sawano, A., Iwai, S., Sakurai, Y., Ito, M., Shitara, K., Nakahata, T., and Shibuya, M. (2001) Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97, 785-791 (Pubitemid 32113414)
16. Thomas, S., Vanuystel, J., Gruden, G., Rodríguez, V., Burt, D., Gnudi, L., Hartley, B., and Viberti, G. (2000) Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease. J. Am. Soc. Nephrol. 11, 1236-1243 (Pubitemid 30416219)
17. Hara, A., Wada, T., Furuichi, K., Sakai, N., Kawachi, H., Shimizu, F., Shibuya, M., Matsushima, K., Yokoyama, H., Egashira, K., and Kaneko, S. (2006) Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis. Kidney Int. 69, 1986-1995 (Pubitemid 43924262)
18. Futrakul, N., Butthep, P., and Futrakul, P. (2008) Altered vascular homeostasis in chronic kidney disease. Clin. Hemorheol. Microcirc. 38, 201-207 (Pubitemid 351185407)
19. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328 (Pubitemid 24324921)
20. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Cao, Y., Moses, M., Lane, W. S., Sage, E. H., and Folkman, J. (1994) Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. Cold Spring Harb. Symp. Quant. Biol. 59, 471-482
21. Petri, M., Kasitanon, N., Lee, S. S., Link, K., Magder, L., Bae, S. C., Hanly, J. G., Isenberg, D. A., Nived, O., Sturfelt, G., van Vollenhoven, R., Wallace, D. J., Alarcon, G. S., Adu, D., Avila-Casado, C., Bernatsky, S. R., Bruce, I. N., Clarke, A. E., Contreras, G., Fine, D. M., Gladman, D. D., Gordon, C., Kalunian, K. C., Madaio, M. P., Rovin, B. H., Sanchez-Guerrero, J., Steinsson, K., Aranow, C., Balow, J. E., Buyon, J. P., Ginzler, E. M., Khamashta, M. A., Urowitz, M. B., Dooley, M. A., Merrill, J. T., Ramsey-Goldman, R., Font, J., Tumlin, J., Stoll, T., and Zoma, A. (2008) Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis Rheum. 58, 1784-1788 (Pubitemid 351847532)
22. Petri, M., Kasitanon, N., Singh, S., Link, K., Magder, L., Bae, S. C., Hanly, J. G., Nived, O., Sturfelt, G., van Vollenhoven, R., Wallace, D. J., Alarcon, G. S., Adu, D., Avila-Casado, C., Bernatsky, S. R., Bruce, I. N., Clarke, A. E., Contreras, G., Fine, D. M., Gladman, D. D., Gordon, C., Kalunian, K. C., Madaio, M. P., Rovin, B. H., Sanchez-Guerrero, J., Steinsson, K., Aranow, C., Balow, J. E., Buyon, J. P., Ginzler, E. M., Khamashta, M. A., Urowitz, M. B., Dooley, M. A., Merrill, J. T., Ramsey-Goldman, R., Font, J., Tumlin, J., Stoll, T., and Zoma, A. (2008) Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. Arthritis Rheum. 58, 1789-1795 (Pubitemid 351847533)
23. Wu, T., Qin, X., Kurepa, Z., Kumar, K. R., Liu, K., Kanta, H., Zhou, X. J., Satterthwaite, A. B., Davis, L. S., and Mohan, C. (2007) Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J. Clin. Invest. 117, 2186-2196 (Pubitemid 47219563)
24. Austin, H. A., 3rd, Muenz, L. R., Joyce, K. M., Antonovych, T. A., Kullick, M. E., Klippel, J. H., Decker, J. L., and Balow, J. E. (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am. J. Med. 75, 382-391 (Pubitemid 13005770)
25. Singh, S., Wu, T., Xie, C., Vanarsa, K., Han, J., Mahajan, T., Oei, H. B., Ahn, C., Zhou, X. J., Putterman, C., Saxena, R., and Mohan, C. (2012) Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis. Arthritis Res. Ther. 14, R164
26. Fiehn, C., Hajjar, Y., Mueller, K., Waldherr, R., Ho, A. D., and Andrassy, K. (2003) Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Ann. Rheum. Dis. 62, 435-439 (Pubitemid 36469735)
27. Reyes-Thomas, J., Blanco, I., and Putterman, C. (2011) Urinary biomarkers in lupus nephritis. Clin. Rev. Allergy. Immunol. 40, 138-150
28. Menke, J., Iwata, Y., Rabacal, W. A., Basu, R., Stanley, E. R., and Kelley, V. R. (2011) Distinct roles of CSF-1 isoforms in lupus nephritis. J Am Soc Nephrol 22, 1821-1833
29. Kiani, A. N., Johnson, K., Chen, C., Diehl, E., Hu, H., Vasudevan, G., Singh, S., Magder, L. S., Knechtle, S. J., and Petri, M. (2009) Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. J. Rheumatol. 36, 2224-2230
30. Dhaun, N., Lilitkarntakul, P., Macintyre, I. M., Muilwijk, E., Johnston, N. R., Kluth, D. C., Webb, D. J., and Goddard, J. (2009) Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis. Am. J. Physiol. Renal Physiol 296, F1477-1483
31. Suzuki, M., Wiers, K., Brooks, E. B., Greis, K. D., Haines, K., Klein-Gitelman, M. S., Olson, J., Onel, K., O'Neil, K. M., Silverman, E. D., Tucker, L., Ying, J., Devarajan, P., and Brunner, H. I. (2009) Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis. Pediatr. Res. 65, 530-536
32. Mastroianni-Kirsztajn, G., Nishida, S. K., and Pereira, A. B. (2008) Are urinary levels of free light chains of immunoglobulins useful markers for differentiating between systemic lupus erythematosus and infection? Nephron Clin. Pract. 110, c258-263
33. Molad, Y., Miroshnik, E., Sulkes, J., Pitlik, S., Weinberger, A., and Monselise, Y. (2002) Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damage. Clin. Exp. Rheumatol. 20, 403-406 (Pubitemid 35012578)
34. Varghese, S. A., Powell, T. B., Budisavljevic, M. N., Oates, J. C., Raymond, J. R., Almeida, J. S., and Arthur, J. M. (2007) Urine biomarkers predict the cause of glomerular disease. J. Am. Soc. Nephrol. 18, 913-922 (Pubitemid 46434508)
35. Rovin, B. H., Song, H., Hebert, L. A., Nadasdy, T., Nadasdy, G., Birmingham, D. J., Yung Yu, C., and Nagaraja, H. N. (2005) Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int. 68, 1825-1833 (Pubitemid 43169928)
36. Castellino, F. J., and Ploplis, V. A. (2005) Structure and function of the plasminogen/plasmin system. Thromb. Haemost. 93, 647-654 (Pubitemid 40485399)
37. Suenson, E., and Thorsen, S. (1981) Secondary-site binding of Gluplasmin, Lys-plasmin and miniplasmin to fibrin. Biochem. J. 197, 619-628 (Pubitemid 11031126)
38. Urano, T., Chibber, B. A., and Castellino, F. J. (1987) The reciprocal effects of epsilon-aminohexanoic acid and chloride ion on the activation of human [Glu1]plasminogen by human urokinase. Proc. Natl. Acad. Sci. U.S.A. 84, 4031-4034 (Pubitemid 17090868)
39. Marunaka, Y. (1997) Hormonal and osmotic regulation of NaCl transport in renal distal nephron epithelium. Jpn. J. Physiol. 47, 499-511
40. Fu, Y., and Zhu, Y. (2010) Ectopic ATP synthase in endothelial cells: a novel cardiovascular therapeutic target. Curr. Pharm. Des. 16, 4074-4079
41. Mu, W., Long, D. A., Ouyang, X., Agarwal, A., Cruz, P. E., Roncal, C. A., Nakagawa, T., Yu, X., Hauswirth, W. W., and Johnson, R. J. (2009) Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism. Am. J. Physiol. Renal Physiol. 296, F145-152